ADC Therapeutics to Participate in September Investor Conferences
Provided By GlobeNewswire
Last update: Sep 5, 2023
LAUSANNE, Switzerland, Sept. 05, 2023 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) today announced that Ameet Mallik, Chief Executive Officer, will participate in two investor conferences in September.
